BACKGROUND: The outcome of patients with non-extremity synovial sarcoma (SS) is generally worse than that of patients with limb tumours. METHODS: The present study analysed a series of 115 consecutive SS patients treated in Italian paediatric protocols (period 1979-2005), mainly focusing on the 30 cases arising from 'axial' sites (16 head-neck, 8 trunk, 4 lung-pleura and 2 retroperitoneum). RESULTS: Initial gross resection was achieved in 40% of axial cases and in 80% of limb SS (p<0.0001). Five-year EFS and overall survival (OS) were, respectively, 43.3% and 55.1% for axial SS, and 69.6% (p=0.0068) and 84.0% (p=0.0004) for extremity SS. Local progression/recurrence was the cause of treatment failure in 75% of relapsing patients axial...
Introduction: Synovial sarcoma (SS) is a malignant mesenchymal tumor. It is most common among childr...
Synovial sarcoma is a high-grade soft tissue sarcoma that inflicts mostly children and young adults ...
We analyzed treatment and outcome in 104 Scandinavian patients with synovial sarcoma in the extremit...
BACKGROUND: The outcome of patients with non-extremity synovial sarcoma (SS) is generally worse than...
Background: The outcome of patients with non-extremity synovial sarcoma (SS) is generally worse than...
BACKGROUND: To report the results of the first European prospective nonrandomized trial dedicated to...
BACKGROUND: To report the results of the first European prospective nonrandomized trial dedicated to...
cords and pathologic findings of 37 children and adoles-cents with synovial sarcoma treated at our i...
PurposeSynovial sarcoma (SS) is the second most common malignant soft tissue tumor in children. ARST...
Background Multimodal risk-adapted treatment is used in paediatric protocols for synovial sarcoma (S...
International audienceTwenty-five to 32% of patients with synovial sarcoma (SS) relapse after approp...
Bernadette Brennan Department of Paediatric Oncology, Royal Manchester Children's Hospital, Manc...
Synovial sarcoma is malignant soft tissue tumor which is the most prevalent in adolescents and young...
Background. There remains controversy on the routine use of chemotherapy in localized SS. Methods. T...
Background: Previous studies have reported a poor outcome for synovial sarcoma patients whose tumour...
Introduction: Synovial sarcoma (SS) is a malignant mesenchymal tumor. It is most common among childr...
Synovial sarcoma is a high-grade soft tissue sarcoma that inflicts mostly children and young adults ...
We analyzed treatment and outcome in 104 Scandinavian patients with synovial sarcoma in the extremit...
BACKGROUND: The outcome of patients with non-extremity synovial sarcoma (SS) is generally worse than...
Background: The outcome of patients with non-extremity synovial sarcoma (SS) is generally worse than...
BACKGROUND: To report the results of the first European prospective nonrandomized trial dedicated to...
BACKGROUND: To report the results of the first European prospective nonrandomized trial dedicated to...
cords and pathologic findings of 37 children and adoles-cents with synovial sarcoma treated at our i...
PurposeSynovial sarcoma (SS) is the second most common malignant soft tissue tumor in children. ARST...
Background Multimodal risk-adapted treatment is used in paediatric protocols for synovial sarcoma (S...
International audienceTwenty-five to 32% of patients with synovial sarcoma (SS) relapse after approp...
Bernadette Brennan Department of Paediatric Oncology, Royal Manchester Children's Hospital, Manc...
Synovial sarcoma is malignant soft tissue tumor which is the most prevalent in adolescents and young...
Background. There remains controversy on the routine use of chemotherapy in localized SS. Methods. T...
Background: Previous studies have reported a poor outcome for synovial sarcoma patients whose tumour...
Introduction: Synovial sarcoma (SS) is a malignant mesenchymal tumor. It is most common among childr...
Synovial sarcoma is a high-grade soft tissue sarcoma that inflicts mostly children and young adults ...
We analyzed treatment and outcome in 104 Scandinavian patients with synovial sarcoma in the extremit...